Your search
Results 117 resources
-
Summary. Investigates factors that lead physicians to be untruthful with patients.
-
Summary. Explores how liability concerns influence physicians to order care that patients don’t need.
-
Summary. Partnership with Dinçer grew out of the Institutional Corruption conference in 2012.
-
Summary. This piece challenges the claim that public health agencies should partner with food companies because they have a “shared responsibility” to address obesity and diet-related non-communicable diseases. Governments should discharge their responsibilities, this piece argues, by effectively regulating industry actors, rather than collaborating with them.
-
Summary. This piece raises the concern that secret settlements with corporate actors (such as oil and gas companies engaged in fracking) may conceal serious threats to public health.
-
Summary. Describes how commonly drug companies fail to adhere to obligations to disclose clinical trial results. My collaboration with Dr. Miller is a direct result of my Safra fellowship.
-
Summary. Of all of my work, these three papers most specifically draw from the the conceptual frames developed in the IC Safra Lab - although their explicit reference to it varies. The risk of IC to public credibility of scientific and scholarly institutions stands at the focus of this work, especially the paradox of the pursuit of value-free science as a value-laden approach to defend this crediblity without accountability.
-
Summary. Describes how common it is for patients’ primary physician to have taken payments from drug companies.
-
Summary. Brazilian voters, particularly political sophisticates, show an ability to distinguish between more and less credible corruption accusations.
-
Summary. The Supreme Court says that campaign finance regulations are unconstitutional unless they target “quid pro quo” corruption or its appearance. To test
-
Summary. Describes hospitals’ practice of double-booking surgeons to maximize revenue.
-
Summary. Explores how liability concerns influence physicians to order care that patients don’t need.
-
Summary. Describes the adverse secondary effects of allowing confidentiality agreements in medical malpractice cases.
-
Summary. Exhorts academic medical centers not to put risk-management and reputational concerns ahead of the need to support clinicians who wish to provide care in epidemic zones.